{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:39:26Z","timestamp":1791639566328,"version":"4.3.4"},"reference-count":94,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Dengue virus belonging to the family Flaviviridae and its four serotypes are responsible for dengue infections, which extend over 60 countries in tropical and subtropical areas of the world including Pakistan. During the ongoing dengue outbreak in Pakistan (2022), over 30,000 cases have been reported, and over 70 lives have been lost. The only commercialized vaccine against DENV, Dengvaxia, cannot be administered as a prophylactic measure to cure this infection due to various complications. Using machine learning and reverse vaccinology approaches, this study was designed to develop a tetravalent modified nucleotide mRNA vaccine using NS1, prM, and EIII sequences of dengue virus from Pakistani isolates. Based on high antigenicity, non-allergenicity, and toxicity profiling, B-cell epitope, cytotoxic T lymphocyte (CTL), and helper T lymphocyte (HTL) putative vaccine targets were predicted. Molecular docking confirmed favorable interactions between T-cell epitopes and their respective HLA alleles, while normal mode analysis validated high-affinity interactions of vaccine proteins with immune receptors. In silico immune simulations confirmed adequate immune responses to eliminate the antigen and generate memory. Codon optimization, physicochemical features, nucleotide modifications, and suitable vector availability further ensured better antigen expression and adaptive immune responses. We predict that this vaccine construct may prove to be a good vaccinal candidate against dengue virus in vitro as well.<\/jats:p>","DOI":"10.3390\/ijms232213911","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T02:29:32Z","timestamp":1668392972000},"page":"13911","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Engineering Modified mRNA-Based Vaccine against Dengue Virus Using Computational and Reverse Vaccinology Approaches"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5363-7342","authenticated-orcid":false,"given":"Mamuna","family":"Mukhtar","sequence":"first","affiliation":[{"name":"Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Sector H-12, Islamabad 44000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amtul Wadood","family":"Wajeeha","sequence":"additional","affiliation":[{"name":"Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Sector H-12, Islamabad 44000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najam us Sahar Sadaf","family":"Zaidi","sequence":"additional","affiliation":[{"name":"Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Sector H-12, Islamabad 44000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseeha","family":"Bibi","sequence":"additional","affiliation":[{"name":"Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Sector H-12, Islamabad 44000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrmicro1690","article-title":"Prospects for a dengue virus vaccine","volume":"5","author":"Whitehead","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1567-1348(03)00004-2","article-title":"The origin, emergence and evolutionary genetics of dengue virus","volume":"3","author":"Holmes","year":"2003","journal-title":"Infect. Genet. Evol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/jme\/tjy010","article-title":"Seasonal Distribution and Container Preference Ratio of the Dengue Fever Vector (Aedes aegypti, Diptera: Culicidae) in Rawalpindi, Pakistan","volume":"55","author":"Mukhtar","year":"2018","journal-title":"J. Med. Entomol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Chong, L.C., and Khan, A.M. (2019). Identification of highly conserved, serotype-specific dengue virus sequences: Implications for vaccine design. BMC Genom., 20.","DOI":"10.1186\/s12864-019-6311-z"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fcimb.2017.00317","article-title":"Global epidemiology of dengue outbreaks in 1990\u20132015: A systematic review and meta-analysis","volume":"7","author":"Guo","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1038\/s41598-017-09199-w","article-title":"Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection","volume":"7","author":"Ali","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/17460441.2020.1811675","article-title":"An update on dengue vaccine development, challenges, and future perspectives","volume":"16","author":"Idris","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ahmed, A., and Khan, G.M. (2021). Dengue Fever Epidemic in Pakistan and Its Control Measures: Where Are We Moving?. Human Viruses: Diseases, Treatments and Vaccines, Springer.","DOI":"10.1007\/978-3-030-71165-8_3"},{"key":"ref_9","unstructured":"World Health Organization (2017). Weekly Epidemiological Monitor."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Naqvi, S.A.A., Jan, B., Shaikh, S., Kazmi, S.J.H., Waseem, L.A., Nasar-u-minAllah, M., and Abbas, N.J.E. (2019). Changing Climatic Factors Favor Dengue Transmission in Lahore, Pakistan. Environments, 6.","DOI":"10.3390\/environments6060071"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.17582\/journal.pjz\/2017.49.3.777.784","article-title":"The role of vertical transmission of dengue virus among field-captured Aedes aegypti and Aedes albopictus mosquitoes in Peshawar, Khyber Pakhtunkhwa, Pakistan","volume":"49","author":"Khan","year":"2017","journal-title":"Pak. J. Zool."},{"key":"ref_12","first-page":"112","article-title":"Adulticidal efficacy of Azadirachta indica (neem tree), Sesamum indicum (til) and Pinus sabinaena (pine tree) extracts against Aedes aegypti under laboratory conditions","volume":"3","author":"Zaki","year":"2015","journal-title":"J. Entomol. Zool. Stud."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jmv.26464","article-title":"Dengue fever and COVID-19 coinfection; a threat to public health for coepidemic in Pakistan","volume":"93","author":"Butt","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mjafi.2014.09.011","article-title":"Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control","volume":"71","author":"Mustafa","year":"2015","journal-title":"Med. J. Armed Force India"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/1995-7645.223529","article-title":"Scenario of dengue infection & its control in Pakistan: An up-date and way forward","volume":"11","author":"Yousaf","year":"2018","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3390\/v3091739","article-title":"Functional RNA Elements in the Dengue Virus Genome","volume":"3","author":"Gebhard","year":"2011","journal-title":"Viruses"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00018-010-0357-z","article-title":"Dengue virus life cycle: Viral and host factors modulating infectivity","volume":"67","author":"Wilschut","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Deng, S.Q., Yang, X., Wei, Y., Chen, J.T., Wang, X.J., and Peng, H.J. (2020). A Review on Dengue Vaccine Development. Vaccines, 8.","DOI":"10.3390\/vaccines8010063"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.humimm.2021.09.006","article-title":"Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand","volume":"83","author":"Thomas","year":"2022","journal-title":"Hum. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(20)30556-0","article-title":"Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2\u201317 years: A randomised, placebo-controlled, phase 2 trial","volume":"395","author":"Tricou","year":"2020","journal-title":"Lancet"},{"key":"ref_21","first-page":"178","article-title":"Dengue vaccine: Global development update","volume":"38","author":"Prompetchara","year":"2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molmed.2019.10.002","article-title":"Tailoring mRNA Vaccine to Balance Innate\/Adaptive Immune Response","volume":"26","author":"Lacroix","year":"2020","journal-title":"Trends Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014A new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41182-022-00410-x","article-title":"The simultaneous crises of dengue and COVID-19 in Pakistan: A double hazard for the country\u2019s debilitated healthcare system","volume":"50","author":"Khatri","year":"2022","journal-title":"Trop. Med. Health"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jmv.26144","article-title":"COVID-19 and dengue virus coepidemics in Pakistan: A dangerous combination for an overburdened healthcare system","volume":"93","author":"Haqqi","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100704","DOI":"10.1016\/j.jemep.2021.100704","article-title":"Dengue, measles, and COVID-19: A threefold challenge to public health security in Pakistan","volume":"19","author":"Yousaf","year":"2021","journal-title":"Ethics Med. Public Health"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1002\/jmv.27241","article-title":"Arboviral diseases and COVID-19 coincidence: Challenges for Pakistan\u2019s derelict healthcare system","volume":"93","author":"Butt","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/2230-8598.161523","article-title":"Dengue epidemic management in a developing country","volume":"5","author":"Nair","year":"2015","journal-title":"Int. J. Med. Public Health"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12275-022-1625-y","article-title":"Current status and perspectives on vaccine development against dengue virus infection","volume":"60","author":"Park","year":"2022","journal-title":"J. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"105447","DOI":"10.1016\/j.micpath.2022.105447","article-title":"A novel strategy for developing a tetravalent vaccine (dvac) against dengue utilizing conserved regions from all DENV proteins","volume":"164","author":"Nasar","year":"2022","journal-title":"Microb. Pathog."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coviro.2020.09.001","article-title":"Dengue mouse models for evaluating pathogenesis and countermeasures","volume":"43","author":"Chen","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1016\/j.sjbs.2021.05.023","article-title":"Dengue and human health: A global scenario of its occurrence, diagnosis and therapeutics","volume":"28","author":"Sabir","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_33","first-page":"129","article-title":"Dengue vaccine candidates in development","volume":"338","author":"Durbin","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wollner, C.J., and Richner, J.M. (2021). mRNA Vaccines against Flaviviruses. Vaccines, 9.","DOI":"10.3390\/vaccines9020148"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lebeau, G., Lagrave, A., Ogire, E., Grondin, L., Seriacaroupin, S., Moutoussamy, C., Mavingui, P., Hoarau, J.-J., Roche, M., and Krejbich-Trotot, P. (2021). Viral toxin NS1 as pivotal target in development of efficient dengue vaccine. Vaccines, 9.","DOI":"10.20944\/preprints202106.0228.v1"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Carpio, K.L., and Barrett, A.D.T. (2021). Flavivirus NS1 and Its Potential in Vaccine Development. Vaccines, 9.","DOI":"10.3390\/vaccines9060622"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1373157","DOI":"10.1155\/2016\/1373157","article-title":"Systematic Bioinformatic Approach for Prediction of Linear B-Cell Epitopes on Dengue E and prM Protein","volume":"2016","author":"Nadugala","year":"2016","journal-title":"Adv. Bioinform."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s00253-018-8822-y","article-title":"Dengue viruses and promising envelope protein domain III-based vaccines","volume":"102","author":"Fahimi","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA Vaccines Protect against Zika Virus Infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-021-03594-0","article-title":"Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses","volume":"594","author":"Saunders","year":"2021","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.molmed.2014.09.003","article-title":"A critical analysis of codon optimization in human therapeutics","volume":"20","author":"Mauro","year":"2014","journal-title":"Trends Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Fox, D.M., Branson, K.M., and Walker, R.C. (2021). mRNA codon optimization with quantum computers. PLoS ONE, 16.","DOI":"10.1101\/2021.02.19.431999"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymeth.2004.06.006","article-title":"Computational methods for prediction of T-cell epitopes\u2014A framework for modelling, testing, and applications","volume":"34","author":"Brusic","year":"2004","journal-title":"Methods"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.virusres.2007.10.010","article-title":"Computational prediction and identification of dengue virus-specific CD4+ T-cell epitopes","volume":"132","author":"Wen","year":"2008","journal-title":"Virus Res."},{"key":"ref_45","first-page":"77","article-title":"In silico prediction of b-cell epitopes of dengue virus\u2014A reverse vaccinology approach","volume":"10","author":"Manikandan","year":"2020","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nbt.1733","article-title":"Expression of therapeutic proteins after delivery of chemically modified mRNA in mice","volume":"29","author":"Kormann","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/08820139.2019.1653908","article-title":"Expression Pattern of Selected Toll-like Receptors (TLR\u2019s) in the PBMC\u2019s of Severe and Non-severe Dengue Cases","volume":"49","author":"Cherupanakkal","year":"2020","journal-title":"Immunol. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Begum, F., Das, S., Mukherjee, D., and Ray, U. (2019). Hijacking the Host Immune Cells by Dengue Virus: Molecular Interplay of Receptors and Dengue Virus Envelope. Microorganisms, 7.","DOI":"10.20944\/preprints201908.0057.v1"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"17118","DOI":"10.1038\/s41598-021-94488-8","article-title":"In-silico design of envelope based multi-epitope vaccine candidate against Kyasanur forest disease virus","volume":"11","author":"Arumugam","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ijbiomac.2020.06.213","article-title":"Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach","volume":"162","author":"Ahammad","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"100430","DOI":"10.1016\/j.imu.2020.100430","article-title":"Delineating blueprint of an epitope-based peptide vaccine against the multiple serovars of dengue virus: A hierarchical reverse vaccinology approach","volume":"20","author":"Islam","year":"2020","journal-title":"Inform. Med. Unlocked"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"100746","DOI":"10.1016\/j.eclinm.2021.100746","article-title":"mRNA vaccines: A matter of delivery","volume":"32","author":"Cao","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2002083","DOI":"10.1080\/21645515.2021.2002083","article-title":"A comprehensive review of SARS-CoV-2 vaccines: Pfizer, moderna & Johnson & Johnson","volume":"18","author":"Patel","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jconrel.2022.03.032","article-title":"mRNA vaccines for COVID-19 and diverse diseases","volume":"345","author":"Hussain","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ymthe.2019.01.020","article-title":"mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases","volume":"27","author":"Maruggi","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4161\/rna.22269","article-title":"Developing mRNA-vaccine technologies","volume":"9","author":"Schlake","year":"2012","journal-title":"RNA Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"W239","DOI":"10.1093\/nar\/gkaa385","article-title":"mRNALoc: A novel machine-learning based in-silico tool to predict mRNA subcellular localization","volume":"48","author":"Garg","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-020-0159-8","article-title":"The promise of mRNA vaccines: A biotech and industrial perspective","volume":"5","author":"Jackson","year":"2020","journal-title":"Npj Vaccines"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.molmed.2013.09.002","article-title":"Challenges and advances towards the rational design of mRNA vaccines","volume":"19","author":"Pollard","year":"2013","journal-title":"Trends Mol. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/bioinformatics\/bts091","article-title":"Unipro UGENE: A unified bioinformatics toolkit","volume":"28","author":"Okonechnikov","year":"2012","journal-title":"Bioinformatics"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2\u2014A multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1093\/bioinformatics\/btz457","article-title":"NX4: A web-based visualization of large multiple sequence alignments","volume":"35","author":"Offenhuber","year":"2019","journal-title":"Bioinformatics"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gki376","article-title":"JCat: A novel tool to adapt codon usage of a target gene to its potential expression host","volume":"33","author":"Grote","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Li, C., Wu, X., Sheridan, S., Lee, J., Wang, X., Yin, J., and Han, J. (2021). Interaction of climate and socio-ecological environment drives the dengue outbreak in epidemic region of China. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009761"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Dziri, S., Rodriguez, C., Gerber, A., Brichler, S., Alloui, C., Roulot, D., Deny, P., Pawlotsky, J.M., Gordien, E., and Le Gal, F. (2021). Variable In Vivo Hepatitis D Virus (HDV) RNA Editing Rates According to the HDV Genotype. Viruses, 13.","DOI":"10.3390\/v13081572"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"W294","DOI":"10.1093\/nar\/gks493","article-title":"GalaxyWEB server for protein structure prediction and refinement","volume":"40","author":"Ko","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_67","first-page":"1","article-title":"Prediction of protein structure and interaction by GALAXY protein modeling programs","volume":"2","author":"Shin","year":"2014","journal-title":"Bio Des."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: Patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"104522","DOI":"10.1016\/j.meegid.2020.104522","article-title":"Inferring the genetic variability in Indian SARS-CoV-2 genomes using consensus of multiple sequence alignment techniques","volume":"85","author":"Saha","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/bab.2128","article-title":"In silico prediction of T-cell and B-cell epitopes of human papillomavirus type 16 L1 protein","volume":"69","author":"Mahmoudvand","year":"2022","journal-title":"Biotechnol. Appl. Biochem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s43141-021-00199-y","article-title":"Screening and characterization of hypothetical proteins of Plasmodium falciparum as novel vaccine candidates in the fight against malaria using reverse vaccinology","volume":"19","author":"Aguttu","year":"2021","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1038\/s41596-021-00628-9","article-title":"The trRosetta server for fast and accurate protein structure prediction","volume":"16","author":"Du","year":"2021","journal-title":"Nat. Protoc."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6718083","DOI":"10.1155\/2018\/6718083","article-title":"Immunoinformatics approach for epitope-based peptide vaccine design and active site prediction against polyprotein of emerging oropouche virus","volume":"2018","author":"Adhikari","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Sabzian-Molaei, F., Nasiri Khalili, M.A., Sabzian-Molaei, M., Shahsavarani, H., Fattah Pour, A., Molaei Rad, A., and Hadi, A. (2022). Urtica dioica Agglutinin: A plant protein candidate for inhibition of SARS-COV-2 receptor-binding domain for control of Covid19 Infection. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0268156"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1007\/s12274-018-2095-8","article-title":"Development of mRNA vaccines and their prophylactic and therapeutic applications","volume":"11","author":"Lee","year":"2018","journal-title":"Nano Res."},{"key":"ref_77","unstructured":"BS, E., Elumalai, E., and Gupta, K.K. Peptide-based epitope design on non-structural proteins of SARS-CoV-2. BioRxiv, 2021."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"107836","DOI":"10.1016\/j.jmgm.2021.107836","article-title":"Epitope mimicry analysis of SARS-COV-2 surface proteins and human lung proteins","volume":"105","author":"Morsy","year":"2021","journal-title":"J. Mol. Graph. Model."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"173781","DOI":"10.1016\/j.ejphar.2020.173781","article-title":"Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis","volume":"891","author":"Okuyan","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"W271","DOI":"10.1093\/nar\/gku339","article-title":"iMODS: Internal coordinates normal mode analysis server","volume":"42","author":"Aliaga","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s10989-020-10157-w","article-title":"A novel multi-epitopic peptide vaccine candidate against Helicobacter pylori: In-silico identification, design, cloning and validation through molecular dynamics","volume":"27","author":"Ghosh","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Gasteiger, E., Hoogland, C., Gattiker, A., Wilkins, M.R., Appel, R.D., and Bairoch, A. (2005). Protein Identification and Analysis Tools on the ExPASy Server. The Proteomics Protocols Handbook, Human Press.","DOI":"10.1385\/1-59259-890-0:571"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10989-021-10359-w","article-title":"Immunoinformatics Insights into the Internalin A and B Proteins to Design a Multi-Epitope Subunit Vaccine for L","volume":"28","author":"Asadollahi","year":"2022","journal-title":"monocytogenes. Int. J. Pept. Res. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Khan, N.T., Zinnia, M.A., and Islam, A. (2022). Modeling mRNA-based vaccine YFV.E1988 against yellow fever virus E-protein using immuno-informatics and reverse vaccinology approach. J. Biomol. Struct. Dyn., 1\u201322.","DOI":"10.1080\/07391102.2021.2024253"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Xu, S., Yang, K., Li, R., and Zhang, L. (2020). mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186582"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2183\/pjab.91.394","article-title":"Discovery of m(7)G-cap in eukaryotic mRNAs","volume":"91","author":"Furuichi","year":"2015","journal-title":"Proc. Jpn. Acad. Phys. Biol. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Xia, X. (2021). Detailed Dissection and Critical Evaluation of the Pfizer\/BioNTech and Moderna mRNA Vaccines. Vaccines, 9.","DOI":"10.3390\/vaccines9070734"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13273-021-00171-4","article-title":"Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency","volume":"18","author":"Kim","year":"2022","journal-title":"Mol. Cell. Toxicol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1021\/acscentsci.1c00197","article-title":"Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines","volume":"7","author":"Nance","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.copbio.2021.09.016","article-title":"Principles for designing an optimal mRNA lipid nanoparticle vaccine","volume":"73","author":"Kon","year":"2022","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41580-021-00417-y","article-title":"Roles of mRNA poly (A) tails in regulation of eukaryotic gene expression","volume":"23","author":"Passmore","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s10989-020-10140-5","article-title":"Designing of nucleocapsid protein based novel multi-epitope vaccine against SARS-COV-2 using immunoinformatics approach","volume":"27","author":"Kumar","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Fatoba, A.J., Adeleke, V.T., Maharaj, L., Okpeku, M., Adeniyi, A.A., and Adeleke, M.A. (2022). Design of a Multiepitope Vaccine against Chicken Anemia Virus Disease. Viruses, 14.","DOI":"10.3390\/v14071456"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/22\/13911\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:14:34Z","timestamp":1760145274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/22\/13911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":94,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijms232213911"],"URL":"https:\/\/doi.org\/10.3390\/ijms232213911","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]}}}